APO Research
Talk to an analyst

APO RESEARCH · REPORT

GM1 Gangliosidosis Treatment

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global GM1 Gangliosidosis Treatment Market Analysis and Forecast 2026-2032

19 December 2025193 pages

Choose your research edition.

Industry ResearchGM1 Gangliosidosis Treatment Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal GM1 Gangliosidosis Treatment Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal GM1 Gangliosidosis Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GM1 Gangliosidosis Treatment Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal GM1 Gangliosidosis Treatment Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global GM1 Gangliosidosis Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for GM1 Gangliosidosis Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for GM1 Gangliosidosis Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for GM1 Gangliosidosis Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for GM1 Gangliosidosis Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of GM1 Gangliosidosis Treatment include Axovant Gene Therapies Ltd and Passage Bio and Lysogene etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for GM1 Gangliosidosis Treatment, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of GM1 Gangliosidosis Treatment, also provides the sales of main regions and countries. Of the upcoming market potential for GM1 Gangliosidosis Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the GM1 Gangliosidosis Treatment sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global GM1 Gangliosidosis Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for GM1 Gangliosidosis Treatment sales, projected growth trends, production technology, application and end-user industry.

GM1 Gangliosidosis Treatment Segment by Company

Axovant Gene Therapies Ltd

Passage Bio and Lysogene

GM1 Gangliosidosis Treatment Segment by Type

AXO-AAV-GM1

LYS-GM101

PBGM01

GM1 Gangliosidosis Treatment Segment by Application

Type 3 GM1 Gangliosidosis

Type 2 GM1 Gangliosidosis

Type 1 GM1 Gangliosidosis

GM1 Gangliosidosis Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GM1 Gangliosidosis Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GM1 Gangliosidosis Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GM1 Gangliosidosis Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of GM1 Gangliosidosis Treatment in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of GM1 Gangliosidosis Treatment manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, GM1 Gangliosidosis Treatment sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global GM1 Gangliosidosis Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. AXO-AAV-GM1 Major Manufacturers Table 3. LYS-GM101 Major Manufacturers Table 4. PBGM01 Major Manufacturers Table 5. Global GM1 Gangliosidosis Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Type 3 GM1 Gangliosidosis Major Manufacturers Table 7. Type 2 GM1 Gangliosidosis Major Manufacturers Table 8. Type 1 GM1 Gangliosidosis Major Manufacturers Table 9. GM1 Gangliosidosis Treatment Industry Trends Table 10. GM1 Gangliosidosis Treatment Industry Drivers Table 11. GM1 Gangliosidosis Treatment Industry Opportunities and Challenges Table 12. GM1 Gangliosidosis Treatment Industry Restraints Table 13. Global GM1 Gangliosidosis Treatment Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global GM1 Gangliosidosis Treatment Revenue by Region (2021-2026) & (US$ Million) Table 15. Global GM1 Gangliosidosis Treatment Revenue by Region (2027-2032) & (US$ Million) Table 16. Global GM1 Gangliosidosis Treatment Revenue Market Share by Region (2021-2026) Table 17. Global GM1 Gangliosidosis Treatment Revenue Market Share by Region (2027-2032) Table 18. Global GM1 Gangliosidosis Treatment Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global GM1 Gangliosidosis Treatment Sales by Region (2021-2026) & (K Units) Table 20. Global GM1 Gangliosidosis Treatment Sales by Region (2027-2032) & (K Units) Table 21. Global GM1 Gangliosidosis Treatment Sales Market Share by Region (2021-2026) Table 22. Global GM1 Gangliosidosis Treatment Sales Market Share by Region (2027-2032) Table 23. Global GM1 Gangliosidosis Treatment Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global GM1 Gangliosidosis Treatment Revenue Market Share by Manufacturers (2021-2026) Table 25. Global GM1 Gangliosidosis Treatment Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global GM1 Gangliosidosis Treatment Sales Market Share by Manufacturers (2021-2026) Table 27. Global GM1 Gangliosidosis Treatment Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global GM1 Gangliosidosis Treatment Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global GM1 Gangliosidosis Treatment Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global GM1 Gangliosidosis Treatment Manufacturers, Product Type & Application Table 31. Global GM1 Gangliosidosis Treatment Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global GM1 Gangliosidosis Treatment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global GM1 Gangliosidosis Treatment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global GM1 Gangliosidosis Treatment Revenue by Type (2021-2026) & (US$ Million) Table 36. Global GM1 Gangliosidosis Treatment Revenue by Type (2027-2032) & (US$ Million) Table 37. Global GM1 Gangliosidosis Treatment Revenue Market Share by Type (2021-2026) Table 38. Global GM1 Gangliosidosis Treatment Revenue Market Share by Type (2027-2032) Table 39. Global GM1 Gangliosidosis Treatment Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global GM1 Gangliosidosis Treatment Sales by Type (2021-2026) & (K Units) Table 41. Global GM1 Gangliosidosis Treatment Sales by Type (2027-2032) & (K Units) Table 42. Global GM1 Gangliosidosis Treatment Sales Market Share by Type (2021-2026) Table 43. Global GM1 Gangliosidosis Treatment Sales Market Share by Type (2027-2032) Table 44. Global GM1 Gangliosidosis Treatment Price by Type (2021-2026) & (US$/Unit) Table 45. Global GM1 Gangliosidosis Treatment Price by Type (2027-2032) & (US$/Unit) Table 46. Global GM1 Gangliosidosis Treatment Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global GM1 Gangliosidosis Treatment Revenue by Application (2021-2026) & (US$ Million) Table 48. Global GM1 Gangliosidosis Treatment Revenue by Application (2027-2032) & (US$ Million) Table 49. Global GM1 Gangliosidosis Treatment Revenue Market Share by Application (2021-2026) Table 50. Global GM1 Gangliosidosis Treatment Revenue Market Share by Application (2027-2032) Table 51. Global GM1 Gangliosidosis Treatment Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global GM1 Gangliosidosis Treatment Sales by Application (2021-2026) & (K Units) Table 53. Global GM1 Gangliosidosis Treatment Sales by Application (2027-2032) & (K Units) Table 54. Global GM1 Gangliosidosis Treatment Sales Market Share by Application (2021-2026) Table 55. Global GM1 Gangliosidosis Treatment Sales Market Share by Application (2027-2032) Table 56. Global GM1 Gangliosidosis Treatment Price by Application (2021-2026) & (US$/Unit) Table 57. Global GM1 Gangliosidosis Treatment Price by Application (2027-2032) & (US$/Unit) Table 58. Axovant Gene Therapies Ltd Company Information Table 59. Axovant Gene Therapies Ltd Business Overview Table 60. Axovant Gene Therapies Ltd GM1 Gangliosidosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Axovant Gene Therapies Ltd GM1 Gangliosidosis Treatment Product Portfolio Table 62. Axovant Gene Therapies Ltd Recent Development Table 63. Passage Bio and Lysogene Company Information Table 64. Passage Bio and Lysogene Business Overview Table 65. Passage Bio and Lysogene GM1 Gangliosidosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Passage Bio and Lysogene GM1 Gangliosidosis Treatment Product Portfolio Table 67. Passage Bio and Lysogene Recent Development Table 68. North America GM1 Gangliosidosis Treatment Revenue by Type (2021-2026) & (US$ Million) Table 69. North America GM1 Gangliosidosis Treatment Revenue by Type (2027-2032) & (US$ Million) Table 70. North America GM1 Gangliosidosis Treatment Sales by Type (2021-2026) & (K Units) Table 71. North America GM1 Gangliosidosis Treatment Sales by Type (2027-2032) & (K Units) Table 72. North America GM1 Gangliosidosis Treatment Sales Price by Type (2021-2026) & (US$/Unit) Table 73. North America GM1 Gangliosidosis Treatment Sales Price by Type (2027-2032) & (US$/Unit) Table 74. North America GM1 Gangliosidosis Treatment Revenue by Application (2021-2026) & (US$ Million) Table 75. North America GM1 Gangliosidosis Treatment Revenue by Application (2027-2032) & (US$ Million) Table 76. North America GM1 Gangliosidosis Treatment Sales by Application (2021-2026) & (K Units) Table 77. North America GM1 Gangliosidosis Treatment Sales by Application (2027-2032) & (K Units) Table 78. North America GM1 Gangliosidosis Treatment Sales Price by Application (2021-2026) & (US$/Unit) Table 79. North America GM1 Gangliosidosis Treatment Sales Price by Application (2027-2032) & (US$/Unit) Table 80. North America GM1 Gangliosidosis Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 81. North America GM1 Gangliosidosis Treatment Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 82. North America GM1 Gangliosidosis Treatment Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 83. North America GM1 Gangliosidosis Treatment Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 84. North America GM1 Gangliosidosis Treatment Sales by Country (2021-2026) & (K Units) Table 85. North America GM1 Gangliosidosis Treatment Sales by Country (2027-2032) & (K Units) Table 86. North America GM1 Gangliosidosis Treatment Sales Price by Country (2021-2026) & (US$/Unit) Table 87. North America GM1 Gangliosidosis Treatment Sales Price by Country (2027-2032) & (US$/Unit) Table 88. United States GM1 Gangliosidosis Treatment Revenue (2021-2032) & (US$ Million) Table 89. Canada GM1 Gangliosidosis Treatment Revenue (2021-2032) & (US$ Million) Table 90. Europe GM1 Gangliosidosis Treatment Revenue by Type (2021-2026) & (US$ Million) Table 91. Europe GM1 Gangliosidosis Treatment Revenue by Type (2027-2032) & (US$ Million) Table 92. Europe GM1 Gangliosidosis Treatment Sales by Type (2021-2026) & (K Units) Table 93. Europe GM1 Gangliosidosis Treatment Sales by Type (2027-2032) & (K Units) Table 94. Europe GM1 Gangliosidosis Treatment Sales Price by Type (2021-2026) & (US$/Unit) Table 95. Europe GM1 Gangliosidosis Treatment Sales Price by Type (2027-2032) & (US$/Unit) Table 96. Europe GM1 Gangliosidosis Treatment Revenue by Application (2021-2026) & (US$ Million) Table 97. Europe GM1 Gangliosidosis Treatment Revenue by Application (2027-2032) & (US$ Million) Table 98. Europe GM1 Gangliosidosis Treatment Sales by Application (2021-2026) & (K Units) Table 99. Europe GM1 Gangliosidosis Treatment Sales by Application (2027-2032) & (K Units) Table 100. Europe GM1 Gangliosidosis Treatment Sales Price by Application (2021-2026) & (US$/Unit) Table 101. Europe GM1 Gangliosidosis Treatment Sales Price by Application (2027-2032) & (US$/Unit) Table 102. Europe GM1 Gangliosidosis Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Europe GM1 Gangliosidosis Treatment Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 104. Europe GM1 Gangliosidosis Treatment Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 105. Europe GM1 Gangliosidosis Treatment Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 106. Europe GM1 Gangliosidosis Treatment Sales by Country (2021-2026) & (K Units) Table 107. Europe GM1 Gangliosidosis Treatment Sales by Country (2027-2032) & (K Units) Table 108. Europe GM1 Gangliosidosis Treatment Sales Price by Country (2021-2026) & (US$/Unit) Table 109. Europe GM1 Gangliosidosis Treatment Sales Price by Country (2027-2032) & (US$/Unit) Table 110. Germany GM1 Gangliosidosis Treatment Revenue (2021-2032) & (US$ Million) Table 111. France GM1 Gangliosidosis Treatment Revenue (2021-2032) & (US$ Million) Table 112. U.K. GM1 Gangliosidosis Treatment Revenue (2021-2032) & (US$ Million) Table 113. Italy GM1 Gangliosidosis Treatment Revenue (2021-2032) & (US$ Million) Table 114. Netherlands GM1 Gangliosidosis Treatment Revenue (2021-2032) & (US$ Million) Table 115. China GM1 Gangliosidosis Treatment Revenue by Type (2021-2026) & (US$ Million) Table 116. China GM1 Gangliosidosis Treatment Revenue by Type (2027-2032) & (US$ Million) Table 117. China GM1 Gangliosidosis Treatment Sales by Type (2021-2026) & (K Units) Table 118. China GM1 Gangliosidosis Treatment Sales by Type (2027-2032) & (K Units) Table 119. China GM1 Gangliosidosis Treatment Sales Price by Type (2021-2026) & (US$/Unit) Table 120. China GM1 Gangliosidosis Treatment Sales Price by Type (2027-2032) & (US$/Unit) Table 121. China GM1 Gangliosidosis Treatment Revenue by Application (2021-2026) & (US$ Million) Table 122. China GM1 Gangliosidosis Treatment Revenue by Application (2027-2032) & (US$ Million) Table 123. China GM1 Gangliosidosis Treatment Sales by Application (2021-2026) & (K Units) Table 124. China GM1 Gangliosidosis Treatment Sales by Application (2027-2032) & (K Units) Table 125. China GM1 Gangliosidosis Treatment Sales Price by Application (2021-2026) & (US$/Unit) Table 126. China GM1 Gangliosidosis Treatment Sales Price by Application (2027-2032) & (US$/Unit) Table 127. Asia GM1 Gangliosidosis Treatment Revenue by Type (2021-2026) & (US$ Million) Table 128. Asia GM1 Gangliosidosis Treatment Revenue by Type (2027-2032) & (US$ Million) Table 129. Asia GM1 Gangliosidosis Treatment Sales by Type (2021-2026) & (K Units) Table 130. Asia GM1 Gangliosidosis Treatment Sales by Type (2027-2032) & (K Units) Table 131. Asia GM1 Gangliosidosis Treatment Sales Price by Type (2021-2026) & (US$/Unit) Table 132. Asia GM1 Gangliosidosis Treatment Sales Price by Type (2027-2032) & (US$/Unit) Table 133. Asia GM1 Gangliosidosis Treatment Revenue by Application (2021-2026) & (US$ Million) Table 134. Asia GM1 Gangliosidosis Treatment Revenue by Application (2027-2032) & (US$ Million) Table 135. Asia GM1 Gangliosidosis Treatment Sales by Application (2021-2026) & (K Units) Table 136. Asia GM1 Gangliosidosis Treatment Sales by Application (2027-2032) & (K Units) Table 137. Asia GM1 Gangliosidosis Treatment Sales Price by Application (2021-2026) & (US$/Unit) Table 138. Asia GM1 Gangliosidosis Treatment Sales Price by Application (2027-2032) & (US$/Unit) Table 139. Asia GM1 Gangliosidosis Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. Asia GM1 Gangliosidosis Treatment Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 141. Asia GM1 Gangliosidosis Treatment Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 142. Asia GM1 Gangliosidosis Treatment Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 143. Asia GM1 Gangliosidosis Treatment Sales by Country (2021-2026) & (K Units) Table 144. Asia GM1 Gangliosidosis Treatment Sales by Country (2027-2032) & (K Units) Table 145. Asia GM1 Gangliosidosis Treatment Sales Price by Country (2021-2026) & (US$/Unit) Table 146. Asia GM1 Gangliosidosis Treatment Sales Price by Country (2027-2032) & (US$/Unit) Table 147. Japan GM1 Gangliosidosis Treatment Revenue (2021-2032) & (US$ Million) Table 148. South Korea GM1 Gangliosidosis Treatment Revenue (2021-2032) & (US$ Million) Table 149. India GM1 Gangliosidosis Treatment Revenue (2021-2032) & (US$ Million) Table 150. Australia GM1 Gangliosidosis Treatment Revenue (2021-2032) & (US$ Million) Table 151. China Taiwan GM1 Gangliosidosis Treatment Revenue (2021-2032) & (US$ Million) Table 152. Southeast Asia GM1 Gangliosidosis Treatment Revenue (2021-2032) & (US$ Million) Table 153. SAMEA GM1 Gangliosidosis Treatment Revenue by Type (2021-2026) & (US$ Million) Table 154. SAMEA GM1 Gangliosidosis Treatment Revenue by Type (2027-2032) & (US$ Million) Table 155. SAMEA GM1 Gangliosidosis Treatment Sales by Type (2021-2026) & (K Units) Table 156. SAMEA GM1 Gangliosidosis Treatment Sales by Type (2027-2032) & (K Units) Table 157. SAMEA GM1 Gangliosidosis Treatment Sales Price by Type (2021-2026) & (US$/Unit) Table 158. SAMEA GM1 Gangliosidosis Treatment Sales Price by Type (2027-2032) & (US$/Unit) Table 159. SAMEA GM1 Gangliosidosis Treatment Revenue by Application (2021-2026) & (US$ Million) Table 160. SAMEA GM1 Gangliosidosis Treatment Revenue by Application (2027-2032) & (US$ Million) Table 161. SAMEA GM1 Gangliosidosis Treatment Sales by Application (2021-2026) & (K Units) Table 162. SAMEA GM1 Gangliosidosis Treatment Sales by Application (2027-2032) & (K Units) Table 163. SAMEA GM1 Gangliosidosis Treatment Sales Price by Application (2021-2026) & (US$/Unit) Table 164. SAMEA GM1 Gangliosidosis Treatment Sales Price by Application (2027-2032) & (US$/Unit) Table 165. SAMEA GM1 Gangliosidosis Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. SAMEA GM1 Gangliosidosis Treatment Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 167. SAMEA GM1 Gangliosidosis Treatment Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 168. SAMEA GM1 Gangliosidosis Treatment Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 169. SAMEA GM1 Gangliosidosis Treatment Sales by Country (2021-2026) & (K Units) Table 170. SAMEA GM1 Gangliosidosis Treatment Sales by Country (2027-2032) & (K Units) Table 171. SAMEA GM1 Gangliosidosis Treatment Sales Price by Country (2021-2026) & (US$/Unit) Table 172. SAMEA GM1 Gangliosidosis Treatment Sales Price by Country (2027-2032) & (US$/Unit) Table 173. Brazil GM1 Gangliosidosis Treatment Revenue (2021-2032) & (US$ Million) Table 174. Argentina GM1 Gangliosidosis Treatment Revenue (2021-2032) & (US$ Million) Table 175. Chile GM1 Gangliosidosis Treatment Revenue (2021-2032) & (US$ Million) Table 176. Colombia GM1 Gangliosidosis Treatment Revenue (2021-2032) & (US$ Million) Table 177. Peru GM1 Gangliosidosis Treatment Revenue (2021-2032) & (US$ Million) Table 178. Saudi Arabia GM1 Gangliosidosis Treatment Revenue (2021-2032) & (US$ Million) Table 179. Israel GM1 Gangliosidosis Treatment Revenue (2021-2032) & (US$ Million) Table 180. UAE GM1 Gangliosidosis Treatment Revenue (2021-2032) & (US$ Million) Table 181. Turkey GM1 Gangliosidosis Treatment Revenue (2021-2032) & (US$ Million) Table 182. Iran GM1 Gangliosidosis Treatment Revenue (2021-2032) & (US$ Million) Table 183. Egypt GM1 Gangliosidosis Treatment Revenue (2021-2032) & (US$ Million) Table 184. Key Raw Materials Table 185. Raw Materials Key Suppliers Table 186. GM1 Gangliosidosis Treatment Distributors List Table 187. GM1 Gangliosidosis Treatment Customers List Table 188. Research Programs/Design for This Report Table 189. Authors List of This Report Table 190. Secondary Sources Table 191. Primary Sources List of Figures Figure 1. GM1 Gangliosidosis Treatment Image Figure 2. Global GM1 Gangliosidosis Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GM1 Gangliosidosis Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 4. AXO-AAV-GM1 Image Figure 5. LYS-GM101 Image Figure 6. PBGM01 Image Figure 7. Global GM1 Gangliosidosis Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global GM1 Gangliosidosis Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 9. Type 3 GM1 Gangliosidosis Image Figure 10. Type 2 GM1 Gangliosidosis Image Figure 11. Type 1 GM1 Gangliosidosis Image Figure 12. Global GM1 Gangliosidosis Treatment Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global GM1 Gangliosidosis Treatment Revenue (2021-2032) & (US$ Million) Figure 14. Global GM1 Gangliosidosis Treatment Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global GM1 Gangliosidosis Treatment Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global GM1 Gangliosidosis Treatment Revenue Market Share by Region (2021-2032) Figure 17. Global GM1 Gangliosidosis Treatment Sales (2021-2032) & (K Units) Figure 18. Global GM1 Gangliosidosis Treatment Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global GM1 Gangliosidosis Treatment Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico GM1 Gangliosidosis Treatment Sales YoY (2021-2032) & (K Units) Figure 21. Europe GM1 Gangliosidosis Treatment Sales YoY (2021-2032) & (K Units) Figure 22. China GM1 Gangliosidosis Treatment Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) GM1 Gangliosidosis Treatment Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa GM1 Gangliosidosis Treatment Sales YoY (2021-2032) & (K Units) Figure 25. Global GM1 Gangliosidosis Treatment Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global GM1 Gangliosidosis Treatment Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global GM1 Gangliosidosis Treatment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global GM1 Gangliosidosis Treatment Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global GM1 Gangliosidosis Treatment Revenue Market Share by Type (2021-2032) Figure 31. Global GM1 Gangliosidosis Treatment Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global GM1 Gangliosidosis Treatment Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global GM1 Gangliosidosis Treatment Sales Market Share by Type (2021-2032) Figure 34. Global GM1 Gangliosidosis Treatment Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global GM1 Gangliosidosis Treatment Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global GM1 Gangliosidosis Treatment Revenue Market Share by Application (2021-2032) Figure 37. Global GM1 Gangliosidosis Treatment Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global GM1 Gangliosidosis Treatment Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global GM1 Gangliosidosis Treatment Sales Market Share by Application (2021-2032) Figure 40. North America GM1 Gangliosidosis Treatment Revenue Share by Type (2021-2032) Figure 41. North America GM1 Gangliosidosis Treatment Sales Share by Type (2021-2032) Figure 42. North America GM1 Gangliosidosis Treatment Revenue Share by Application (2021-2032) Figure 43. North America GM1 Gangliosidosis Treatment Sales Share by Application (2021-2032) Figure 44. North America GM1 Gangliosidosis Treatment Revenue Share by Country (2021-2032) Figure 45. North America GM1 Gangliosidosis Treatment Sales Share by Country (2021-2032) Figure 46. Europe GM1 Gangliosidosis Treatment Revenue Share by Type (2021-2032) Figure 47. Europe GM1 Gangliosidosis Treatment Sales Share by Type (2021-2032) Figure 48. Europe GM1 Gangliosidosis Treatment Revenue Share by Application (2021-2032) Figure 49. Europe GM1 Gangliosidosis Treatment Sales Share by Application (2021-2032) Figure 50. Europe GM1 Gangliosidosis Treatment Revenue Share by Country (2021-2032) Figure 51. Europe GM1 Gangliosidosis Treatment Sales Share by Country (2021-2032) Figure 52. China GM1 Gangliosidosis Treatment Revenue Share by Type (2021-2032) Figure 53. China GM1 Gangliosidosis Treatment Sales Share by Type (2021-2032) Figure 54. China GM1 Gangliosidosis Treatment Revenue Share by Application (2021-2032) Figure 55. China GM1 Gangliosidosis Treatment Sales Share by Application (2021-2032) Figure 56. Asia GM1 Gangliosidosis Treatment Revenue Share by Type (2021-2032) Figure 57. Asia GM1 Gangliosidosis Treatment Sales Share by Type (2021-2032) Figure 58. Asia GM1 Gangliosidosis Treatment Revenue Share by Application (2021-2032) Figure 59. Asia GM1 Gangliosidosis Treatment Sales Share by Application (2021-2032) Figure 60. Asia GM1 Gangliosidosis Treatment Revenue Share by Country (2021-2032) Figure 61. Asia GM1 Gangliosidosis Treatment Sales Share by Country (2021-2032) Figure 62. SAMEA GM1 Gangliosidosis Treatment Revenue Share by Type (2021-2032) Figure 63. SAMEA GM1 Gangliosidosis Treatment Sales Share by Type (2021-2032) Figure 64. SAMEA GM1 Gangliosidosis Treatment Revenue Share by Application (2021-2032) Figure 65. SAMEA GM1 Gangliosidosis Treatment Sales Share by Application (2021-2032) Figure 66. SAMEA GM1 Gangliosidosis Treatment Revenue Share by Country (2021-2032) Figure 67. SAMEA GM1 Gangliosidosis Treatment Sales Share by Country (2021-2032) Figure 68. GM1 Gangliosidosis Treatment Value Chain Figure 69. Manufacturing Cost Structure Figure 70. GM1 Gangliosidosis Treatment Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • AXO-AAV-GM1
  • LYS-GM101
  • PBGM01
Applications
  • Type 3 GM1 Gangliosidosis
  • Type 2 GM1 Gangliosidosis
  • Type 1 GM1 Gangliosidosis
Companies covered
  • Axovant Gene Therapies Ltd
  • Passage Bio and Lysogene

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 GM1 Gangliosidosis Treatment Market by Type
  3. 1.2.1 Global GM1 Gangliosidosis Treatment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 AXO-AAV-GM1
  5. 1.2.3 LYS-GM101
  6. 1.2.4 PBGM01
  7. 1.3 GM1 Gangliosidosis Treatment Market by Application
  8. 1.3.1 Global GM1 Gangliosidosis Treatment Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Type 3 GM1 Gangliosidosis
  10. 1.3.3 Type 2 GM1 Gangliosidosis
  11. 1.3.4 Type 1 GM1 Gangliosidosis
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 GM1 Gangliosidosis Treatment Market Dynamics
  1. 2.1 GM1 Gangliosidosis Treatment Industry Trends
  2. 2.2 GM1 Gangliosidosis Treatment Industry Drivers
  3. 2.3 GM1 Gangliosidosis Treatment Industry Opportunities and Challenges
  4. 2.4 GM1 Gangliosidosis Treatment Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global GM1 Gangliosidosis Treatment Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global GM1 Gangliosidosis Treatment Revenue by Region
  3. 3.2.1 Global GM1 Gangliosidosis Treatment Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global GM1 Gangliosidosis Treatment Revenue by Region (2021-2026)
  5. 3.2.3 Global GM1 Gangliosidosis Treatment Revenue by Region (2027-2032)
  6. 3.2.4 Global GM1 Gangliosidosis Treatment Revenue Market Share by Region (2021-2032)
  7. 3.3 Global GM1 Gangliosidosis Treatment Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global GM1 Gangliosidosis Treatment Sales by Region
  9. 3.4.1 Global GM1 Gangliosidosis Treatment Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global GM1 Gangliosidosis Treatment Sales by Region (2021-2026)
  11. 3.4.3 Global GM1 Gangliosidosis Treatment Sales by Region (2027-2032)
  12. 3.4.4 Global GM1 Gangliosidosis Treatment Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global GM1 Gangliosidosis Treatment Revenue by Manufacturers
  2. 4.1.1 Global GM1 Gangliosidosis Treatment Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global GM1 Gangliosidosis Treatment Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global GM1 Gangliosidosis Treatment Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global GM1 Gangliosidosis Treatment Sales by Manufacturers
  6. 4.2.1 Global GM1 Gangliosidosis Treatment Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global GM1 Gangliosidosis Treatment Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global GM1 Gangliosidosis Treatment Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global GM1 Gangliosidosis Treatment Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global GM1 Gangliosidosis Treatment Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global GM1 Gangliosidosis Treatment Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global GM1 Gangliosidosis Treatment Manufacturers, Product Type & Application
  13. 4.7 Global GM1 Gangliosidosis Treatment Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global GM1 Gangliosidosis Treatment Market CR5 and HHI
  16. 4.8.2 2025 GM1 Gangliosidosis Treatment Tier 1, Tier 2, and Tier 3
5 GM1 Gangliosidosis Treatment Market by Type
  1. 5.1 Global GM1 Gangliosidosis Treatment Revenue by Type
  2. 5.1.1 Global GM1 Gangliosidosis Treatment Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global GM1 Gangliosidosis Treatment Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global GM1 Gangliosidosis Treatment Revenue Market Share by Type (2021-2032)
  5. 5.2 Global GM1 Gangliosidosis Treatment Sales by Type
  6. 5.2.1 Global GM1 Gangliosidosis Treatment Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global GM1 Gangliosidosis Treatment Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global GM1 Gangliosidosis Treatment Sales Market Share by Type (2021-2032)
  9. 5.3 Global GM1 Gangliosidosis Treatment Price by Type
6 GM1 Gangliosidosis Treatment Market by Application
  1. 6.1 Global GM1 Gangliosidosis Treatment Revenue by Application
  2. 6.1.1 Global GM1 Gangliosidosis Treatment Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global GM1 Gangliosidosis Treatment Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global GM1 Gangliosidosis Treatment Revenue Market Share by Application (2021-2032)
  5. 6.2 Global GM1 Gangliosidosis Treatment Sales by Application
  6. 6.2.1 Global GM1 Gangliosidosis Treatment Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global GM1 Gangliosidosis Treatment Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global GM1 Gangliosidosis Treatment Sales Market Share by Application (2021-2032)
  9. 6.3 Global GM1 Gangliosidosis Treatment Price by Application
7 Company Profiles
  1. 7.1 Axovant Gene Therapies Ltd
  2. 7.1.1 Axovant Gene Therapies Ltd Company Information
  3. 7.1.2 Axovant Gene Therapies Ltd Business Overview
  4. 7.1.3 Axovant Gene Therapies Ltd GM1 Gangliosidosis Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Axovant Gene Therapies Ltd GM1 Gangliosidosis Treatment Product Portfolio
  6. 7.1.5 Axovant Gene Therapies Ltd Recent Developments
  7. 7.2 Passage Bio and Lysogene
  8. 7.2.1 Passage Bio and Lysogene Company Information
  9. 7.2.2 Passage Bio and Lysogene Business Overview
  10. 7.2.3 Passage Bio and Lysogene GM1 Gangliosidosis Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Passage Bio and Lysogene GM1 Gangliosidosis Treatment Product Portfolio
  12. 7.2.5 Passage Bio and Lysogene Recent Developments
8 North America
  1. 8.1 North America GM1 Gangliosidosis Treatment Market Size by Type
  2. 8.1.1 North America GM1 Gangliosidosis Treatment Revenue by Type (2021-2032)
  3. 8.1.2 North America GM1 Gangliosidosis Treatment Sales by Type (2021-2032)
  4. 8.1.3 North America GM1 Gangliosidosis Treatment Price by Type (2021-2032)
  5. 8.2 North America GM1 Gangliosidosis Treatment Market Size by Application
  6. 8.2.1 North America GM1 Gangliosidosis Treatment Revenue by Application (2021-2032)
  7. 8.2.2 North America GM1 Gangliosidosis Treatment Sales by Application (2021-2032)
  8. 8.2.3 North America GM1 Gangliosidosis Treatment Price by Application (2021-2032)
  9. 8.3 North America GM1 Gangliosidosis Treatment Market Size by Country
  10. 8.3.1 North America GM1 Gangliosidosis Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America GM1 Gangliosidosis Treatment Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America GM1 Gangliosidosis Treatment Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe GM1 Gangliosidosis Treatment Market Size by Type
  2. 9.1.1 Europe GM1 Gangliosidosis Treatment Revenue by Type (2021-2032)
  3. 9.1.2 Europe GM1 Gangliosidosis Treatment Sales by Type (2021-2032)
  4. 9.1.3 Europe GM1 Gangliosidosis Treatment Price by Type (2021-2032)
  5. 9.2 Europe GM1 Gangliosidosis Treatment Market Size by Application
  6. 9.2.1 Europe GM1 Gangliosidosis Treatment Revenue by Application (2021-2032)
  7. 9.2.2 Europe GM1 Gangliosidosis Treatment Sales by Application (2021-2032)
  8. 9.2.3 Europe GM1 Gangliosidosis Treatment Price by Application (2021-2032)
  9. 9.3 Europe GM1 Gangliosidosis Treatment Market Size by Country
  10. 9.3.1 Europe GM1 Gangliosidosis Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe GM1 Gangliosidosis Treatment Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe GM1 Gangliosidosis Treatment Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China GM1 Gangliosidosis Treatment Market Size by Type
  2. 10.1.1 China GM1 Gangliosidosis Treatment Revenue by Type (2021-2032)
  3. 10.1.2 China GM1 Gangliosidosis Treatment Sales by Type (2021-2032)
  4. 10.1.3 China GM1 Gangliosidosis Treatment Price by Type (2021-2032)
  5. 10.2 China GM1 Gangliosidosis Treatment Market Size by Application
  6. 10.2.1 China GM1 Gangliosidosis Treatment Revenue by Application (2021-2032)
  7. 10.2.2 China GM1 Gangliosidosis Treatment Sales by Application (2021-2032)
  8. 10.2.3 China GM1 Gangliosidosis Treatment Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia GM1 Gangliosidosis Treatment Market Size by Type
  2. 11.1.1 Asia GM1 Gangliosidosis Treatment Revenue by Type (2021-2032)
  3. 11.1.2 Asia GM1 Gangliosidosis Treatment Sales by Type (2021-2032)
  4. 11.1.3 Asia GM1 Gangliosidosis Treatment Price by Type (2021-2032)
  5. 11.2 Asia GM1 Gangliosidosis Treatment Market Size by Application
  6. 11.2.1 Asia GM1 Gangliosidosis Treatment Revenue by Application (2021-2032)
  7. 11.2.2 Asia GM1 Gangliosidosis Treatment Sales by Application (2021-2032)
  8. 11.2.3 Asia GM1 Gangliosidosis Treatment Price by Application (2021-2032)
  9. 11.3 Asia GM1 Gangliosidosis Treatment Market Size by Country
  10. 11.3.1 Asia GM1 Gangliosidosis Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia GM1 Gangliosidosis Treatment Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia GM1 Gangliosidosis Treatment Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA GM1 Gangliosidosis Treatment Market Size by Type
  2. 12.1.1 SAMEA GM1 Gangliosidosis Treatment Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA GM1 Gangliosidosis Treatment Sales by Type (2021-2032)
  4. 12.1.3 SAMEA GM1 Gangliosidosis Treatment Price by Type (2021-2032)
  5. 12.2 SAMEA GM1 Gangliosidosis Treatment Market Size by Application
  6. 12.2.1 SAMEA GM1 Gangliosidosis Treatment Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA GM1 Gangliosidosis Treatment Sales by Application (2021-2032)
  8. 12.2.3 SAMEA GM1 Gangliosidosis Treatment Price by Application (2021-2032)
  9. 12.3 SAMEA GM1 Gangliosidosis Treatment Market Size by Country
  10. 12.3.1 SAMEA GM1 Gangliosidosis Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA GM1 Gangliosidosis Treatment Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA GM1 Gangliosidosis Treatment Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 GM1 Gangliosidosis Treatment Value Chain Analysis
  2. 13.1.1 GM1 Gangliosidosis Treatment Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 GM1 Gangliosidosis Treatment Production Mode & Process
  6. 13.2 GM1 Gangliosidosis Treatment Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 GM1 Gangliosidosis Treatment Distributors
  9. 13.2.3 GM1 Gangliosidosis Treatment Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst